Clinical Trial Update: 6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province [NA]

View source ↗

Summary

A clinical trial is evaluating a 6-month regimen using bedaquiline, delamanid, linezolid, and levofloxacin in rifampicin-resistant tuberculosis patients in Hube…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rifampicin-resistant Tuberculosis
• Tuberculosis

Drugs mentioned

• Delamanid (delamanid)
• Levofloxacin (Levofloxacin)
• Linezolid (Linezolid)
• bedaquiline (bedaquiline)

Snippet

Sponsor: Wuhan Pulmonary Hospital | Conditions: Treat to Target, Treatment Duration | NA | Status: NOT_YET_RECRUITING